Platform Session B (non-accredited)
20 Mar 2025
Meeting Room:
Petree Hall C
Laboratory Genetics and Genomics
,
Prenatal Genetics
-
Accredited:
- Not Accredited
Platform presentations are abstract submissions chosen by the abstract review committee to orally present their research. It is a 13-minute presentation followed by a 2-minute Q&A.
O55 - Evaluation of a Large Cohort of Spontaneous Pregnancy Losses: Intriguing Findings From Both Chromosome and Microarray Studies
O59 - Next Generation Sequencing in Blastocyst Stage Embryos: Results of over 41,000 Trophectoderm Biopsy Samples
O60 - AFF2 Gene Variants Identified Through Carrier Screening for Fragile XE Syndrome
O62 - Frequency and Implications of Likely Maternal Segmental Aneusomies Identified on Cell-Free DNA Prenatal Screening
O55 - Evaluation of a Large Cohort of Spontaneous Pregnancy Losses: Intriguing Findings From Both Chromosome and Microarray Studies
O59 - Next Generation Sequencing in Blastocyst Stage Embryos: Results of over 41,000 Trophectoderm Biopsy Samples
O60 - AFF2 Gene Variants Identified Through Carrier Screening for Fragile XE Syndrome
O62 - Frequency and Implications of Likely Maternal Segmental Aneusomies Identified on Cell-Free DNA Prenatal Screening
Agenda
-
Welcome12:00 PM – 1:00 PM -
12:00 PM – 1:00 PM -
Evaluation of a Large Cohort of Spontaneous Pregnancy Losses: Intriguing Finding from Both Chromosome and Microarray Studies12:00 PM – 12:15 PM -
Next Generation Sequencing in Blastocyst Stage Embryos: Results of over 41,000 Trophectoderm Biopsy Samples12:15 PM – 12:30 PM -
AFF2 Gene Variants Identified Through Carrier Screening for Fragile XE Syndrome12:30 PM – 12:45 PM -
Frequency and Implications of Likely Maternal Segmental Aneusomies Identified on Cell-Free DNA Prenatal Screening12:45 PM – 1:00 PM
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
)
)
)
)
){kind=logo}
){kind=logo}
){kind=logo}